Rice Biotech Launch Pad startup Motif Neurotech closes Series A financing of $18.75 million
Jan 24, 2024
1 min read
Funding to develop miniature implantable stimulator to unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders.
HOUSTON – (Jan. 24, 2023) – Rice University today announced that Motif Neurotech, a neurotechnology company developing minimally invasive bioelectronics for mental health formed through the Rice Biotech Launch Pad, closed an oversubscribed Series A financing round of $18.75 million.
Read more here.
A Rice Biotech Launch Pad startup closing an 18.75 million dollar Series A for a miniature implantable stimulator is a real milestone for a university spinout. Explaining the science in a short clip is the hard part. Making a clip from one image is what AI Fruit does.